Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.50
Bid: 309.00
Ask: 310.50
Change: -8.50 (-2.70%)
Spread: 1.50 (0.485%)
Open: 311.50
High: 312.50
Low: 302.00
Prev. Close: 315.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: BoA likes Dowlais; JPMorgan cuts Phoenix Group

Fri, 22nd Sep 2023 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

UBS raises Next price target to 7,250 (6,850) pence - 'neutral'

----------

SocGen raises Next price target to 8,287 (8,239) pence - 'buy'

----------

JPMorgan raises Next price target to 7,500 (7,300) pence - 'neutral'

----------

JPMorgan raises Next price target to 7,500 (7,300) pence - 'neutral'

----------

Goldman Sachs cuts SSE price target to 2,390 (2,431) pence - 'buy'

----------

JPMorgan raises M&G price target to 195 (180) pence - 'underweight'

----------

JPMorgan raises Admiral Group price target to 1,700 (1,650) pence - 'underweight'

----------

JPMorgan cuts Phoenix Group to 'underweight' (neutral) - price target 500 (655) pence

----------

JPMorgan cuts Prudential price target to 1,500 (1,630) pence - 'overweight'

----------

JPMorgan cuts Legal & General price target to 290 (315) pence - 'overweight'

----------

RBC raises Hargreaves Lansdown target to 900 (875) pence - 'sector perform'

----------

Deutsche Bank cuts Lloyds Banking price target to 62 (63) pence - 'buy'

----------

Deutsche Bank cuts Barclays price target to 200 (230) pence - 'hold'

----------

Deutsche Bank cuts NatWest price target to 320 (370) pence - 'buy'

----------

JPMorgan raises BP price target to 600 (530) pence - 'neutral'

----------

JPMorgan raises Shell price target to 3,200 (2,750) pence - 'overweight'

----------

FTSE 250

----------

Bank of America starts Dowlais with 'buy' - price target 144 pence

----------

Jefferies cuts Victrex price target to 1,420 (1,590) pence - 'hold'

----------

JPMorgan raises Hiscox to 'overweight' (neutral) - price target 1,300 (1,200) pence

----------

JPMorgan raises Just Group price target to 125 (120) pence - 'overweight'

----------

JPMorgan cuts Lancashire to 'neutral' (overweight) - price target 715 (750) pence

----------

Berenberg cuts Mobico Group price target to 140 (220) pence - 'buy'

----------

Deutsche Bank cuts Dunelm price target to 1,310 (1,340) pence - 'buy'

----------

Deutsche Bank cuts Virgin Money UK target to 210 (220) pence - 'hold'

----------

SMALL CAP

----------

Berenberg raises DFS Furniture price target to 185 (155) pence - 'buy'

----------

JPMorgan cuts Oxford BioMedica price target to 325 (495) pence - 'neutral'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Apr 2016 12:54

DIRECTOR DEALINGS: Oxford Biomedica Executive Director Buys Shares

Read more
28 Apr 2016 08:37

Oxford Biomedica Loss Widens As Research Spending And Staff Grow

Read more
25 Apr 2016 08:29

DIRECTOR DEALINGS: Oxford BioMedica Chairman Ups Interest

Read more
21 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Apr 2016 06:39

IXICO Enters Parkinson's Consortium And Secures Oxford Biomedica Deal

Read more
24 Mar 2016 11:14

DIRECTOR DEALINGS: Oxford Biomedica Chairman Ups Interest

Read more
7 Mar 2016 09:25

Oxford BioMedica Expands Collaboration, Inks Deal With Immune Design

Read more
25 Feb 2016 18:03

DIRECTOR DEALINGS: Oxford BioMedica Chairman Buys First Shares

Read more
23 Feb 2016 12:23

Oxford Biomedica to raise £8.1m in placing

(ShareCast News) - Biopharmaceutical company Oxford Biomedica plans to raise £8.1m in a placing of 128.4m shares at 6.3p with new and existing investors. The placing, which is priced at a 10% discount to the 7p closing price on 22 February, is to provide adequate working capital for the group to con

Read more
23 Feb 2016 08:26

Oxford BioMedica To Raise GBP8.1 Million In Discounted Placing (ALLISS)

Read more
29 Jan 2016 08:09

Oxford Biomedica Starts New Programme Under Novartis Deal

Read more
13 Jan 2016 08:43

Oxford Biomedica Gets UK Bulk Drug Manufacturing Approvals

Read more
15 Dec 2015 08:57

Oxford Biomedica Names Lorenzo Tallarigo As New Chairman

Read more
4 Nov 2015 10:42

Oxford BioMedica Making Progress On Strategy And Clinical Trials

Read more
28 Oct 2015 08:49

Oxford Biomedica Says Glaxo Exercises LentiVector Platform Option

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.